Effect of Simulated Weight Loss on the Energy Cost of Locomotion in Overweight or Obese Adolescents
NCT ID: NCT07155746
Last Updated: 2025-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
20 participants
INTERVENTIONAL
2025-09-12
2027-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It seems necessary to study in greater depth the energy adaptations to weight variations in young people with obesity, both metabolic and mechanical, in order to better understand the control of their energy balance and the mechanisms involved, which corresponds to the objectives of this project.
The objective of this project is therefore to study energy adaptations (energy cost and use of energy substrates) to simulated weight loss during incremental walking exercise. Adolescents with obesity will perform a walking exercise on an AlterG (anti-gravity) treadmill, first without and then with a simulated weight loss that places them in the overweight or normal weight category.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physical Activity and Food Intake Interaction: Effect of Weight Loss in Obese Adolescent
NCT02664844
Energy Intake and Exercise Timing
NCT03807609
Physical Activity Program and Energy Intake Control in Obese Adolescents
NCT02482220
Influence of Cardio-ventilatory Factors on Exercise Intolerance in Obese Adolescents: Effects of Exercise Training
NCT01411605
Effect of a Physical Activity Program on the Hormonal Regulation of Food Intake
NCT01824680
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adolescents aged 12 to 16 with obesity defined as a BMI above the 97th percentile
3 different walking exercises
Incremental walking exercise on an AlterG treadmill (anti-gravity)
One visit with their current weight (BW) One visit with simulated weight loss in adolescents to determine their normal weight (NW-SBW) One visit with simulated weight loss in adolescents to determine their overweight status (OW-SBW).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Incremental walking exercise on an AlterG treadmill (anti-gravity)
One visit with their current weight (BW) One visit with simulated weight loss in adolescents to determine their normal weight (NW-SBW) One visit with simulated weight loss in adolescents to determine their overweight status (OW-SBW).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No regular consumption of tobacco or alcohol,
* No diet (no calorie restriction, no specific diet such as a normal-calorie diet enriched with protein, vegetarian, or other),
* Adolescents affiliated with the social security system or equivalent,
* Adolescent who has been informed and has given written consent to participate in the study,
* Signed consent of both holders of parental authority (or one in the event of death, major incapacity, or withdrawal of parental authority).
Exclusion Criteria
* Refusal of consent by parents or guardians,
* Participation in regular and intense physical and sporting activities (no more than 150 minutes of moderate structured activity per week (according to WHO recommendations),
* Medical or surgical history deemed by the investigator to be incompatible with the study,
* Presence of diabetes or any other condition limiting the application of either strategy being tested,
* Adolescents undergoing energy restriction or a weight loss program through physical activity at the time of inclusion or during the previous 6 months,
* Taking medications that may interfere with the study results.
* Adolescents with cardiovascular problems, i.e., subjects with a history of cardiovascular and/or neurovascular disease, as well as subjects with cardiovascular and/or neurovascular risk factors (excluding obesity/overweight).
* Surgery in the previous 3 months,
* Adolescents who are currently excluded from another study,
* Pregnant or breastfeeding adolescents,
* Adolescents under guardianship/curatorship or legal protection,
* Parents under guardianship/curatorship or legal protection.
12 Years
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Emile Roux
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David THIVEL Director of AME2P Laboratory - CLERMONT-FERRAND University
Role: PRINCIPAL_INVESTIGATOR
Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
David THIVEL Director of AME2P Laboratory - CLERMONT-FERRAND University
Role: CONTACT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-A01209-40
Identifier Type: OTHER
Identifier Source: secondary_id
RIPH2_GADEA_DELOAD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.